Amoy Diagnostics Co., Ltd. (SHE:300685)
China · Delayed Price · Currency is CNY 17.99
-1.91 (-9.60%)
Jun 8, 2026, 3:04 PM CST
Amoy Diagnostics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Amoy Diagnostics stock has a consensus rating of "Strong Buy" and an average price target of ¥29.08. The average 1-year stock price forecast is 61.65% higher than the current stock price, while the lowest is ¥28.00 (+55.64%) and the highest is ¥30.30 (+68.43%).
Price Target: ¥29.08 (+61.65%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Amoy Diagnostics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 7 | 6 | 6 |
Financial Forecast
Revenue This Year
1.40B
from 1.20B
Increased by 16.99%
Revenue Next Year
1.59B
from 1.40B
Increased by 13.22%
EPS This Year
1.00
from 0.86
Increased by 16.28%
EPS Next Year
1.21
from 1.00
Increased by 21.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6B | ||
| Avg | 1.4B | ||
| Low | 1.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 33.5% | ||
| Avg | 17.0% | ||
| Low | 10.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.00 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 16.3% | ||
| Low | - |